A carregar...
Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement
Amyotrophic lateral sclerosis (ALS) is a clinically progressive neurodegenerative syndrome predominantly affecting motor neurons and their associated tracts. Riluzole and edaravone are the only FDA certified drugs for treating ALS. Over the past two decades, almost all clinical trials aiming to deve...
Na minha lista:
| Publicado no: | Front Neurol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5626834/ https://ncbi.nlm.nih.gov/pubmed/29033893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2017.00521 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|